Bluebird Bio, Inc. logo

Bluebird Bio, Inc. Share Price Today (NASDAQ: BLUE)

Bluebird Bio, Inc. share price is $4.97 & ₹427.74 as on 29 May 2025 IST

$4.97

Market is closed - opens 7 PM, 16 Jun 2025

Bell Icon

The stock has been delisted from the stock exchange on 30 May 2025

View live Bluebird Bio, Inc. share price in Dollar and Rupees. Guide to invest in Bluebird Bio, Inc. stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Bluebird Bio, Inc., along with analyst recommendations, forecasts, and comprehensive financials.

Bluebird Bio, Inc. (BLUE) Key Statistics

in dollars & INR

Previous Close
$4.97
Open
$4.74
Market Capitalization
$48.7M
Today's Volume
$1.2M
Revenue TTM
$103.9M
EBITDA
$-149.2M
Earnings Per Share (EPS)
$-20.59
Profit Margin
-192.39%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-546.54%

How to invest in Bluebird Bio, Inc. Stock (BLUE) from India?

It is very easy for Indian residents to invest directly in Bluebird Bio, Inc. from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Bluebird Bio, Inc. stock in both Indian Rupees (INR) and US Dollars (USD). Search for Bluebird Bio, Inc. or BLUE on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Bluebird Bio, Inc. or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Bluebird Bio, Inc. shares which would translate to 0.173 fractional shares of Bluebird Bio, Inc. as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India , including recognised companies like Bluebird Bio, Inc., in just a few clicks!

Global Institutional Holdings in Bluebird Bio, Inc.

  • BlackRock Inc

    7.13%

  • Vanguard Group Inc

    5.29%

  • TANG CAPITAL MANAGEMENT LLC

    4.08%

  • Geode Capital Management, LLC

    2.51%

  • State Street Corp

    2.00%

  • EQUITEC PROPRIETARY MARKETS, LLC

    1.13%

Analyst Recommendation on Bluebird Bio, Inc.

Rating
Trend

Buy

    50%Buy

    40%Hold

    10%Sell

Based on 20 Wall street analysts offering stock ratings for Bluebird Bio, Inc.(by analysts ranked 0 to 5 stars)

About Bluebird Bio, Inc.

bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes gene therapies for curative severe genetic diseases in the United States. The company's product candidates for severe genetic diseases include ZYNTEGLO (betibeglogene autotemcel) for the treatment of transfusion-dependent ß-thalassemia; LYFGENIA (lovotibeglogene autotemcel) for the treatment of sickle cell disease (SCD) and a history of vaso-occlusive events; and SKYSONA (elivaldogene autotemcel) to treat cerebral adrenoleukodystrophy. Its clinical development programs include HGB-205, HGB-206, and HGB-210 to evaluate the safety and efficacy of lovo-cel in the treatment of patients with SCD; and HGB-204, HGB-205, HGB-207, and HGB-212 to evaluate the safety and efficacy of beti-cel in the treatment of patients with ß-thalassemia. The company was formerly known as Genetix Pharmaceuticals, Inc., and changed its name to bluebird bio, Inc. in September 2010. bluebird bio, Inc. was incorporated in 1992 and is headquartered in Somerville, Massachusetts.
Organization
Bluebird Bio, Inc.
Employees
248
CEO
Mr. Andrew Obenshain
Industry
Health Technology

Management People of Bluebird Bio, Inc.

NameTitle
Mr. Andrew Obenshain
President, CEO & Director
Mr. Thomas J. Klima
Chief Commercial & Operating Officer
Mr. Joseph D. Vittiglio Esq., J.D.
Chief Legal & Business Officer and Secretary
Mr. Oliver James Sterling III
CFO & Principal Accounting Officer
Ms. Andrea Walton
Chief People Officer
Dr. Richard A. Colvin M.D., Ph.D.
Chief Medical Officer
Mr. Scott Shoemaker
Senior Vice President of Technical Operations

Important FAQs about investing in BLUE Stock from India :

Can Indians buy Bluebird Bio, Inc. shares?

Yes, Indians can invest in the Bluebird Bio, Inc. (BLUE) from India.

With INDmoney, you can buy Bluebird Bio, Inc. at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Bluebird Bio, Inc. at zero transaction cost.

How can I buy Bluebird Bio, Inc. shares from India?

It is very easy to buy Bluebird Bio, Inc. from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Bluebird Bio, Inc. (BLUE) be purchased?

Yes, you can buy fractional shares of Bluebird Bio, Inc. with INDmoney app.

What are the documents required to start investing in Bluebird Bio, Inc. stocks?

To start investing in Bluebird Bio, Inc., You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What is today's market capitalisation of Bluebird Bio, Inc.?

Today's market capitalisation of Bluebird Bio, Inc. BLUE is 48.7M

Who is the Chief Executive Officer (CEO) of Bluebird Bio, Inc. ?

Mr. Andrew Obenshain is the current Chief Executive Officer (CEO) of Bluebird Bio, Inc..